SYDNEY, Oct. 17, 2012 /PRNewswire/ -- Results of a landmark study by Australian and New Zealand researchers comparing starch fluid for resuscitation of patients in intensive care units (ICUs) has shown that it has significant impact on patients when compared to normal saline.
The findings of CHEST (The Crystalloid vs Hydroxyethyl Starch Trial) will be published tomorrow in the New England Journal of Medicine and will change the way patients are treated in ICUs across the world.
The results of the study will be provided in a special media briefing at Royal North Shore Hospital by:
Professor Simon Finfer from The George Institute for Global Health
Media conference will be held in the ICU Conference Room, level 6 of the main building, Royal North Shore Hospital (Use Westbourne Street entrance of hospital: exit the Pacific Highway onto Westbourne St and enter opposite the North Shore Private Hospital).
Thursday, October 18, 2012 at 11.25 am EDT (Sydney)
Media can also join by phone at 11.25am on:
International dial-in number: +61 2 8823 6760
Australia toll free dial-in number: 1 800 354 715
Quote conference ID # 48910753
For information contact
Director Global Communications for The George Institute,
+61 408 808 895,
Communications Manager Australia,
+61 410 411 983,
SOURCE www.georgeinstitute.org.au The George Institute